Christopher Hite
Chairman
Royalty Pharma plc (RPRX)Board Member
Vera Therapeutics, Inc. (VERA)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-01-01–present
-
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Royalty Pharma plc (RPRX) | Executive Vice President & Vice Chairman | $1,323,000 | $1,323,000 |
| 2024 | Royalty Pharma plc (RPRX) | Executive Vice President & Vice Chairman | $1,260,000 | $1,260,000 |
| 2023 | Royalty Pharma plc (RPRX) | Executive Vice President & Vice Chairman | $1,200,000 | $4,560,000 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.